THC Therapeutics acquires SugarTop Buddery in all-share deal valued at ~$3M

THC Therapeutics, Inc.

Acquired 100% of ST Holdings Group (SugarTop Buddery) for 3,000 Series D Preferred shares valued at ~$3M.
SugarTop Buddery generated ~$2.1M in 2024 revenue (peak $4.3M in 2022); 10-year craft cannabis brand.
Founder/CEO Anna Kaplan joins THCT; brand noted for female-founded leadership and music-inspired craft cannabis.
This is THCT's second strategic acquisition in 2025, following The Headquarters Group in June.
THCT expands Oregon operations, targeting a bi-coastal national cannabis platform.

item 1.01item 2.01item 3.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.